Published in Vaccine Weekly, December 9th, 1996
In preliminary research, Italian researchers determined that the transduction of the murine IFN-(alpha)1 gene into various metastatic mouse tumor cells could result in a loss of tumorigenicity and an acquired capacity to induce long-lasting antitumor immunity after injection of these modified cells into immunocompetent syngeneic mice (M. Ferrantini et al., Cancer Res., 1993;53:1107; M. Ferrantini et al., J. Immunol., 1994;153:4604;...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly